Compile Data Set for Download or QSAR
Report error Found 240 Enz. Inhib. hit(s) with all data for entry = 13189
TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765686(3-(1-(4-chloro-2-fluorophenyl) ethoxy)-N5-cyclobut...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765746(N5-cyclobutyl-N2-methyl-3-(1-phenylethoxy)-1H-pyrr...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765671(3-(1-(4-chlorophenyl) ethoxy)-N5-ethyl-N2-methyl-1...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765714((S)-3-(1-(4-chlorophenyl) ethoxy)-N-methyl-5-(5-me...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765681(3-(1-(4-chlorophenyl) ethoxy)-N5-cyclobutyl-N2-met...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765697(N5-ethyl-3-(1-(4-iodophenyl) ethoxy)-N2-methyl-1H-...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765713((S)-3-(1-(2-fluorophenyl) ethoxy)-N-methyl-5-(5-me...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765727((S)-N-methyl-3-(1-phenylethoxy)-5-(1-(trifluoromet...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765715(N5-ethyl-3-(1-(4-ethynylphenyl) ethoxy)-N2-methyl-...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765724((S)-5-(1-isopropyl-1H-pyrazol-4-yl)-N-methyl-3-(1-...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765679(N5-ethyl-N2-methyl-3-(1-(p-tolyl) ethoxy)-1H-pyrro...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765695(3-(1-(4-bromophenyl) ethoxy)-N5-ethyl-N2-methyl-1H...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765675((S)-N-methyl-5-(5-methyl-1H-imidazol-2-yl)-3-(1-ph...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765707((S)-3-(1-(4-chlorophenyl) ethoxy)-N5-cyclopropyl-N...)
Affinity DataIC50: 50nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765744(N5-(trans-4-methoxycyclohexyl)-N2-methyl-3-(1-phen...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765685(3-(1-(5-chloropyridin-2-yl) ethoxy)-N5-cyclobutyl-...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765732((S)-N-methyl-5-(1-methyl-1H-pyrazol-4-yl)-3-(1-phe...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765688(3-(1-(4-chloro-2-fluorophenyl) ethoxy)-N5-(trans-4...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765731((S)-5-(4,5-dimethyl-1H-imidazol-2-yl)-N-methyl-3-(...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765725((S)-5-(1,3-dimethyl-1H-pyrazol-5-yl)-N-methyl-3-(1...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765684(3-(1-(4-chlorophenyl) ethoxy)-N2-methyl-N5-(oxetan...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765742(N5-(trans-4-hydroxycyclohexyl)-N2-methyl-3-(1-phen...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765683(3-(1-(4-chlorophenyl) ethoxy)-N5-(4-hydroxycyclohe...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765753(N5-(trans-3-hydroxycyclobutyl)-N2-methyl-3-((S)-1-...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765694(3-(1-(2-fluorophenyl) ethoxy)-N2-methyl-N5-(oxetan...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765752((S)-N2-methyl-N5-(oxetan-3-yl)-3-(1-phenylethoxy)-...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765719(N5-ethyl-3-(1-(4-methoxy phenyl) ethoxy)-N2-methyl...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765693(3-(1-(2-fluorophenyl) ethoxy)-N-(trans-4-hydroxycy...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765761(N5-(trans-3-hydroxycyclopentyl)-N2-methyl-3-((S)-1...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765760(N5-((1S,3S)-3-hydroxycyclopentyl)-N2-methyl-3-((S)...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765658(N5-ethyl-N2-methyl-3-(1-(o-tolyl) ethoxy)-1H-pyrro...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765773((S)-5-Acetamido-3-(1-(2-fluorophenyl)ethoxy)-N-met...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765748(N5-(4,4-difluorocyclohexyl)-N2-methyl-3-(1-phenyle...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765689(3-(1-(4-chloro-2-fluorophenyl) ethoxy)-N2-methyl-N...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765751((S)-N5-cyclopropyl-N2-methyl-3-(1-phenylethoxy)-1H...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765692(N5-cyclobutyl-3-(1-(2-fluorophenyl) ethoxy)-N2-met...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765655(N5-ethyl-N2-methyl-3-(1-(2-(trifluoromethyl) pheny...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765670(N5-ethyl-N2-methyl-3-(1-(m-tolyl) ethoxy)-1H-pyrro...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765767(3-(1-(4-chlorophenyl) ethoxy)-N5-ethyl-N2-methyl-1...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765704((S)-N5-cyclopropyl-3-(1-(2-fluorophenyl) ethoxy)-N...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765769(N5-ethyl-3-(1-(2-fluorophenyl) ethoxy)-N2-methyl-1...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765656(3-(1-(3-chlorophenyl) ethoxy)-N5-ethyl-N2-methyl-1...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765703((S)-3-(1-(2-fluorophenyl) ethoxy)-N5-isopropyl-N2-...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765763((S)-N5-(3-hydroxybicyclo [1.1.1]pentan-1-yl)-N2-me...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765733((S)-5-(1H-imidazol-2-yl)-N-methyl-3-(1-phenylethox...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765762((S)-N5-(bicyclo [1.1.1]pentan-1-yl)-N2-methyl-3-(1...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765700((S)-N2-methyl-3-(1-phenylethoxy)-N5-(2,2,2-trifluo...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765699(3-(benzhydryloxy)-N5-ethyl-N2-methyl-1H-pyrrole-2,...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765706((S)-3-(1-(4-chlorophenyl) ethoxy)-N5-isopropyl-N2-...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4 [348-457](Human)
Tay Therapeutics

US Patent
LigandPNGBDBM765772(N5-ethyl-3-(1-(4-fluorophenyl) ethoxy)-N2-methyl-1...)
Affinity DataIC50: 350nMAssay Description:NanoBRET assay was carried out according to the manufacturer's suggested protocol (Promega, Madison, WI). HEK293 cells were transfected using Nan...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

Displayed 1 to 50 (of 240 total ) | Next | Last >>
Jump to: